PATHWORK TISSUE OF ORIGIN TEST KIT-FFPE (ORIGIN TEST KIT-FFPE
Overview
The PATHWORK TISSUE OF ORIGIN TEST KIT-FFPE is a molecular diagnostic test designed to assist physicians in determining the primary site of origin for challenging cancer cases. It utilizes microarray-based RNA profiling to analyze gene expression patterns in formalin-fixed, paraffin-embedded (FFPE) tumor specimens. The test compares the patient’s tumor profile to a proprietary database of fifteen known tumor types, employing a machine learning-developed algorithm to generate Similarity Scores. This information aids in the diagnosis of poorly differentiated, undifferentiated, and metastatic tumors when the tissue of origin is uncertain after initial diagnostic workup. The kit includes the Pathchip® microarray, reagents, software, a Specimen Processing Guide, and a Guide to Report Interpretation.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Microarray-based RNA profiling for gene expression analysis
- Compares tumor gene expression patterns to a database of 15 known tumor types
- Utilizes proprietary analytics and Pathchipu00ae microarray
- Generates 15 Similarity Scores indicating likelihood for each potential tissue of origin
- Designed for formalin-fixed, paraffin-embedded (FFPE) tissue specimens
- Aids in diagnosis of poorly differentiated, undifferentiated, and metastatic tumors
- FDA-cleared as an in vitro diagnostic (IVD) kit
- Includes reagents, software, and guides for specimen processing and report interpretation
- Algorithm developed using machine learning methods and a large specimen database
- Produces a comprehensive clinical report for physician interpretation
Use Cases
- Determining the primary site of origin for metastatic or poorly differentiated tumors
- Guiding evidence-based treatment decisions for cancer patients
- Identifying the origin of carcinoma of unknown primary (CUP)
- Complementing conventional pathology and immunohistochemistry when diagnosis is uncertain
- Enabling enrollment in appropriate clinical trials based on tumor origin
What Physicians Need to Know
The Pathwork Tissue of Origin Test Kit-FFPE is particularly valuable for cases of metastatic, poorly differentiated, or undifferentiated tumors where the primary site is not readily identifiable through conventional methods. The results should be interpreted by a qualified physician in conjunction with the patient's clinical history and other diagnostic findings, such as immunohistochemistry. The test requires a minimum of 60% viable tumor in the FFPE specimen for optimal performance. While the test can handle up to 40% necrotic tissue, care should be taken to limit specimen exposure to RNases during handling.
The Pathwork Tissue of Origin Test Kit-FFPE is designed to be integrated into existing clinical laboratory workflows. It utilizes the Affymetrix GeneChip System 3000Dx for microarray analysis. The included transmission software facilitates data upload to Pathwork for analysis and subsequent receipt of a comprehensive clinical report.
Details
| Category | Oncology AI, Pathology AI |
| Pricing | Contact for pricing |
| Deployment | Lab-based test kit (for use in clinical laboratories); also offered as a service through CLIA-certified laboratories. |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Oncology, Pathology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2010-06-08 | K092967 510(k) | PATHWORK TISSUE OF ORIGIN TEST KIT-FFPE (ORIGIN TEST KIT-FFPE |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate PATHWORK TISSUE OF ORIGIN TEST KIT-FFPE (ORIGIN TEST KIT-FFPE
Videos
Product demos, reviews, and walkthroughs for PATHWORK TISSUE OF ORIGIN TEST KIT-FFPE (ORIGIN TEST KIT-FFPE.





